|
Eosinophil cationic protein (ECP) |
Plasmodium falciparum |
Plasma |
|
|
> |
|
|
> |
= |
|
|
73 |
Plasma levels ↓ 30 days post-treatment; + correlation with EPX, TNF and sIL-2R; + correlation with eosinophil count 30 days posttreatment; ↓ eosinophil counts on admission, but ↑ during treatment |
Kurtzhals et al., 1998, Clin Exp Immunol |
Link |
|
Eosinophil protein X (EPX) |
Plasmodium falciparum |
Plasma |
|
|
> |
|
|
> |
= |
|
|
73 |
+ correlation with ECP, TNF and sIL-2R; + correlation with eosinophil count 30 days posttreatment |
Kurtzhals et al., 1998, Clin Exp Immunol |
Link |
|
Epinephrine |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
= |
|
|
= |
25 |
N.I. |
Blümer et al., 2005, Metabolism |
Link |
|
Epinephrine |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
= |
16 |
N.I. |
Dekker et al., 1997, Am J Physiol |
Link |
|
EPO |
Plasmodium falciparum |
CSF |
> |
|
|
|
|
|
|
|
|
124 |
CMseq = CMnseq |
Casals-Pascual et al., 2008, Proc Natl Acad Sci U S A |
Link |
|
EPO |
Plasmodium falciparum |
Plasma |
< |
|
|
|
|
|
|
|
|
124 |
CM† < CMseq < CMnseq; protection against neurological sequelae |
Casals-Pascual et al., 2008, Proc Natl Acad Sci U S A |
Link |
|
EPO |
Plasmodium falciparum |
Plasma |
|
|
< |
|
|
|
> |
|
> |
211 |
SMA > CM |
Diez-Padrisa et al., 2011, PLoS One |
Link |
|
EPO |
Plasmodium falciparum |
Serum |
|
|
|
|
|
|
|
|
|
87 |
Levels anemic patients > levels non-anemic patients |
Leowattana et al., 2008, Southeast Asian J Trop Med Public Health |
Link |
|
Factor B |
Plasmodium falciparum |
Serum |
|
|
|
|
|
|
= |
|
n.s. |
283 |
N.I. |
Phanuphak et al., 1985, Clin Exp Immunol |
Link |
|
Factor II+VII+X |
Plasmodium falciparum, Plasmodium vivax |
Plasma |
|
|
|
|
|
|
|
> |
< |
61 |
P. falciparum = P. vivax; no correlation with platelet count; - correlation with sIL-2R and sTNF-R1 |
Bygbjerg et al., 1997, APMIS |
Link |
|
Factor IX |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
= |
|
= |
54 |
N.I. |
Hemmer et al., 1991, Am J Med |
Link |
|
Factor V |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
15 |
SM (renal failure)admission = SM (renal failure)recovery = within normal limits |
Sitprija et al., 1977, Nephron |
Link |
|
Factor VIII |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
15 |
SM (renal failure)admission = SM (renal failure)recovery = within normal limits |
Sitprija et al., 1977, Nephron |
Link |
|
Factor VIII |
Plasmodium falciparum |
Plasma |
|
|
= |
|
|
|
|
|
|
58 |
CM = NCSM > HC |
Larkin et al., 2009 PLoS Pathog |
Link |
|
Factor XII |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
32 |
SM < HC |
Clemens et al., 1994, Br J Haematol |
Link |
|
Factor XIII |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
< |
|
= |
45 |
This is true for F.XIII subunit a and b and for F.XIII activity; - correlation with neutrophil elastase and parasitemia |
Holst et al., 1999, Am J Trop Med Hyg |
Link |
|
Ferritin |
Plasmodium falciparum |
Plasma |
|
> |
|
|
|
|
> |
|
> |
679 |
UM hospitalized > UM not-hospitalized; + correlation with lactate; - correlation with Hb |
O'Donnell et al., 2009, Trans R Soc Trop Med Hyg |
Link |
|
Ferritin |
Plasmodium falciparum |
Plasma/Serum |
|
|
= |
|
|
≥ |
> |
= |
> |
179 |
Plasma: CM > UM; serum: CM ns UM; CM > NM; SM/NCSM = NM |
Burté et al., 2013, Blood |
Link |
|
FFA |
N.I. |
Plasma |
|
|
|
|
|
|
|
|
|
186 |
SM = NM |
Kawo et al., 1990, Lancet |
Link |
|
FFA |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
13 |
CM = HC |
Van Thien et al., 2001, QJM |
Link |
|
FFA |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
= |
|
|
= |
25 |
N.I. |
Blümer et al., 2005, Metabolism |
Link |
|
FGF basic protein |
Plasmodium falciparum |
CSF (PM) |
|
|
= |
|
= |
|
|
|
|
19 |
N.I. |
Armah et al., 2007, Malar J |
Link |
|
FGF basic protein |
Plasmodium falciparum |
Serum |
|
|
|
|
|
|
|
|
|
20 |
SM on admission < SM day7 > SM day14; SM on admission = HC; + correlation between FGFday7 and AST + ALT (admission) and parasite clearance time |
Burgmann et al., 1996, J Clin Immunol |
Link |
|
FGF basic protein |
Plasmodium falciparum |
Serum (PM) |
|
|
= |
|
= |
|
|
|
|
19 |
N.I. |
Armah et al., 2007, Malar J |
Link |
|
Fibrin |
Plasmodium falciparum |
Brain (PM)-IHC |
|
|
|
> |
|
|
|
|
|
16 |
+ correlation with pRBC sequestration |
Moxon et al., 2013, Blood |
Link |
|
Fibrin degradation products (FDP) |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
15 |
SM (renal failure)admission > SM (renal failure)recovery |
Sitprija et al., 1977, Nephron |
Link |
|
Fibrin degradation products (FDP) |
Plasmodium falciparum |
Serum |
|
|
|
|
|
|
|
|
|
29 |
Malaria > HC, especially in patients with CM or ↑ parasitemia |
Sucharit et al., 1975, Southeast Asian J Trop Med Public Health |
Link |
|
Fibrin degradation products (FDP) |
Plasmodium falciparum |
Serum |
|
|
> |
|
|
|
= |
|
|
35 |
N.I. |
Reid et al., 1972, Lancet |
Link |
|
Fibrin degradation products (FDP) |
Plasmodium falciparum |
Serum |
|
|
|
|
|
|
|
|
|
89 |
CM > NM; - correlation with serum C3 values |
Greenwood et al., 1974, Clin Exp Immunol |
Link |
|
Fibrin degradation products (FDP) |
Plasmodium falciparum |
Serum |
|
|
|
|
|
|
= |
|
|
52 |
N.I. |
Pukrittayakamee et al., 1989, Trans R Soc Trop Med Hyg |
Link |
|
Fibrin degradation products (FDP) |
Plasmodium falciparum |
Serum |
|
|
|
|
|
> |
> |
|
|
24 |
N.I. |
Jaroonvesama et al., 1972, Lancet |
Link |
|
Fibrin degradation products (FDP) |
Plasmodium falciparum, Plasmodium vivax |
Serum |
|
|
|
|
|
|
|
|
> |
166 |
Malaria (P. falciparum + P. vivax) > HC; fibrinolytic activity P. falciparum > HC (not for P. vivax) |
Rojanasthien et al., 1992, J Med Assoc Thai |
Link |
|
Fibrinogen |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
67 |
Malaria < HC; - correlation with plasma FPA |
Jimmy et al., 1995, Cent Afr J Med |
Link |
|
Fibrinogen |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
= |
|
|
= |
97 |
Similar thrombin clot time (TCT) between groups; - correlation with TCT |
Akingbola et al., 2006, Niger Postgrad Med J |
Link |
|
Fibrinogen |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
= |
|
|
52 |
N.I. |
Pukrittayakamee et al., 1989, Trans R Soc Trop Med Hyg |
Link |
|
Fibrinogen |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
15 |
SM (renal failure)admission > SM (renal failure)recovery; other coagulation factors were normal (prothrombine time and partial thromboplastin time) |
Sitprija et al., 1977, Nephron |
Link |
|
Fibrinogen |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
54 |
Abnormal only in 3 patients with extremely ↑ parasitemia, ↓ PC antigen and activity and ↑ TAT plasma concentrations; + correlation with PC (Ag and activity); - correlation with parasitemia and TNF-a |
Hemmer et al., 1991, Am J Med |
Link |
|
Fibrinogen |
Plasmodium falciparum, Plasmodium vivax |
Plasma |
|
|
|
|
|
|
= |
|
= |
50 |
UM = P. vivax; only ↑ in 2 cases with DIC |
Jaroonvesama et al., 1975, Southeast Asian J Trop Med Public Health |
Link |
|
Fibrinogen leakage |
Plasmodium falciparum |
Brain (PM)-IHC |
|
|
= |
|
> |
|
|
|
|
24 |
N.I. |
Brown et al., 1999, Neuropathol Appl Neurobiol |
Link |
|
Fibrinopeptide A (FPA) |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
67 |
Malaria > HC; - correlation with plasma fibrinogen; + correlation with parasitemia |
Jimmy et al., 1995, Cent Afr J Med |
Link |
|
G-CSF |
Plasmodium falciparum |
CSF |
|
|
|
|
> |
|
|
|
|
84 |
CM patients: CSF = Serum |
John et al., 2008, Am J Trop Med Hyg |
Link |
|
G-CSF |
Plasmodium falciparum |
CSF (PM) |
|
|
= |
|
= |
|
|
|
|
19 |
N.I. |
Armah et al., 2007, Malar J |
Link |
|
G-CSF |
Plasmodium falciparum |
Serum |
> |
|
|
|
|
= |
|
|
|
209 |
CM > HC |
John et al., 2008, Cytokine |
Link |
|
G-CSF |
Plasmodium falciparum |
Serum (PM) |
|
|
= |
|
= |
|
|
|
|
19 |
N.I. |
Armah et al., 2007, Malar J |
Link |
|
Glucagon |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
25 |
CM + UM > HC |
Blümer et al., 2005, Metabolism |
Link |
|
Glucagon |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
> |
16 |
N.I. |
Dekker et al., 1997, Am J Physiol |
Link |
|
Glucose |
N.I. |
Blood |
|
|
|
|
|
|
|
|
|
186 |
SM = NM |
Kawo et al., 1990, Lancet |
Link |
|
Glucose |
N.I. |
Plasma |
= |
|
|
|
|
|
|
|
|
50 |
N.I. |
Oguche et al., 2002, West Afr J Med |
Link |
|
Glucose |
Plasmodium falciparum |
Blood |
|
|
|
|
|
|
= |
|
|
56 |
N.I. |
Löwenberg et al., 2010, Thromb Heamost |
Link |
|
Glucose |
Plasmodium falciparum |
Blood |
|
< |
|
|
|
|
|
|
|
115 |
- correlation with venous blood lactate concentrations; logistic regression indicated glucose levels < 2.2 mmol/L as an independently predictive of fatal outcome |
Krishna et al., 1994, Trans R Soc Trop Med Hyg |
Link |
|
Glucose |
Plasmodium falciparum |
Blood |
|
|
|
|
|
|
= |
|
|
118 |
N.I. |
Agbenyega et al., 1997, Trans R Soc Trop Med Hyg |
Link |
|
Glucose |
Plasmodium falciparum |
Blood |
|
|
|
|
|
|
|
|
|
68 |
SM = HC (recoverd from UM) |
Sasi et al., 2007, Am J Trop Med Hyg |
Link |
|
Glucose |
Plasmodium falciparum |
CSF |
|
|
|
< |
< |
|
|
|
|
46 |
No overlap between CM range and range of viral encephalitis; CSF glucose below cut-off value (3.4 mmol/L) is 100% specific for CM |
Jakka et al., 2006, Cerebrospinal Fluid Res |
Link |
|
Glucose |
Plasmodium falciparum |
CSF |
|
|
|
|
|
|
|
|
|
23 |
CM patients had similar levels during coma on admission and after recovery from coma |
Davis et al., 1995, J Infect |
Link |
|
Glucose |
Plasmodium falciparum |
Plasma |
|
= |
|
|
|
|
|
|
|
306 |
SM† = SMseq; hyperparasitemia/prostration, CM > RD |
English et al., 1997, QJM |
Link |
|
Glucose |
Plasmodium falciparum |
Plasma |
|
< |
|
|
|
|
|
|
|
400 |
Hypoglycemia is a good predictor of a fatal outcome; - correlation with NT-proBNP, h-FABP, CK-MB and myoglobin |
Ehrhardt et al., 2005, Microbes Infect |
Link |
|
Glucose |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
25 |
Glucose production: CM > UM > HC; + correlation with plasma adiponectin |
Blümer et al., 2005, Metabolism |
Link |
|
Glucose |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
13 |
CM > HC; glucose production was ↑ in CM group and was 100% derived from gluconeogenesis |
Van Thien et al., 2001, QJM |
Link |
|
Glucose |
Plasmodium falciparum |
Plasma |
|
= |
|
|
|
|
|
|
|
24 |
N.I. |
Dondorp et al., 1998, Am J Trop Med Hyg |
Link |
|
Glucose |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
35 |
SM = HC |
Davis et al., 1995, J Infect |
Link |
|
Glucose |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
16 |
Glucose production was ↑ in UM group and was 50% more derived from gluconeogenesis compared to HC |
Dekker et al., 1997, Am J Physiol |
Link |
|
Glucose |
Plasmodium falciparum |
Plasma/Serum |
|
= |
|
|
|
|
|
|
|
81 |
MOD = CM |
Manish et al., 2003, Trop Med Int Health |
Link |
|
Glutamic acid |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
50 |
Malaria (UM + CM) = HC |
Enwonwu et al., 1999, QJM |
Link |
|
Glycerol |
N.I. |
Blood |
|
|
|
|
|
|
|
|
|
186 |
SM = NM |
Kawo et al., 1990, Lancet |
Link |
|
Glycerol |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
13 |
CM = HC |
Van Thien et al., 2001, QJM |
Link |
|
Glycine |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
50 |
Malaria (UM + CM) = HC |
Enwonwu et al., 1999, QJM |
Link |
|
Glycine-rich b-glycoprotein (GBG) |
Plasmodium falciparum |
Serum |
|
|
|
|
|
< |
|
= |
|
89 |
N.I. |
Greenwood et al., 1974, Clin Exp Immunol |
Link |
|
GM-CSF |
Plasmodium falciparum |
CSF (PM) |
|
|
= |
|
= |
|
|
|
|
19 |
N.I. |
Armah et al., 2007, Malar J |
Link |
|
GM-CSF |
Plasmodium falciparum |
Serum |
|
|
= |
|
|
< |
= |
> |
> |
179 |
CM = NM; SM/NCSM > NM; + correlation with serum IL-10, IL-6 and TNF in all patient groups (UM, CM, and SMA) and with IL-1b in UM and SMA patients (but not in CM patients) |
Burté et al., 2013, Blood |
Link |
|
GM-CSF |
Plasmodium falciparum |
Serum (PM) |
|
|
= |
|
= |
|
|
|
|
19 |
N.I. |
Armah et al., 2007, Malar J |
Link |
|
GM-CSF |
Plasmodium vivax |
Plasma |
|
|
|
|
|
|
|
|
> |
99 |
HC were the same patients 3 weeks after treatment |
Abeles et al., 2013, Am J Trop Med Hyg |
Link |
|
Haptoglobin |
Plasmodium falciparum |
Plasma |
|
= |
|
|
|
|
|
|
< |
567 |
SM > UM hospitalized < UM not-hospitalized; + correlation with Hb and glucose; - correlation with Blantyre coma score and bicarbonate |
O'Donnell et al., 2009, Trans R Soc Trop Med Hyg |
Link |
|
HDL-cholesterol |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
< |
37 |
NM (febrile children) = HC |
Agbedana at al., 1990, Ann Trop Med Parasitol |
Link |
|
HDL-cholesterol |
Plasmodium falciparum |
Serum |
|
|
|
|
|
|
|
|
= |
74 |
N.I. |
Djoumessi et al., 1989, Pathol Biol (Paris) |
Link |
|
HDL-cholesterol |
Plasmodium falciparum |
Serum |
|
|
|
|
|
|
|
|
|
35 |
SM < HC |
Davis et al., 1995, J Infect |
Link |
|
HDL-cholesterol |
Plasmodium falciparum, Plasmodium vivax |
Serum |
|
|
|
|
|
|
|
|
< |
28 |
P. falciparum = P. vivax; + correlation with plasma lyso-PAF |
Davis et al., 1993, J Infect |
Link |
|
HDL-cholesterol |
Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale |
Plasma |
|
|
|
|
|
|
|
|
< |
16 |
Levels were normalized at follow-up after 2 weeks |
Nilsson-Ehle et al., 1990, J Intern Med |
Link |
|
HDL:total cholesterol |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
= |
= |
37 |
NM (febrile children) = HC |
Agbedana at al., 1990, Ann Trop Med Parasitol |
Link |
|
HDL:total cholesterol |
Plasmodium falciparum |
Serum |
|
|
|
|
|
|
|
|
|
35 |
SM < HC |
Davis et al., 1995, J Infect |
Link |
|
HDL:total cholesterol |
Plasmodium falciparum, Plasmodium vivax |
Serum |
|
|
|
|
|
|
|
|
< |
28 |
P. falciparum = P. vivax |
Davis et al., 1993, J Infect |
Link |
|
Heart-type fatty acid-binding protein (H-FABP) |
Plasmodium falciparum |
Plasma |
|
> |
|
|
|
|
> |
|
|
400 |
Elevated H-FABP is a good predictor of a fatal outcome; + correlation with plasma NT-proBNP, myoglobin, CK-MB, impaired consciousness, CM and blood lactate levels; - correlation with glucose levels and Hb |
Ehrhardt et al., 2005, Microbes Infect |
Link |
|
Hepcidin |
Plasmodium falciparum |
Plasma/Serum |
|
|
= |
|
|
< |
< |
> |
> |
179 |
CM = NM/HC; SMA > NM/HC |
Burté et al., 2013, Blood |
Link |
|
His:ΣNAA (%) |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
50 |
Malaria (UM + CM) > HC |
Enwonwu et al., 1999, QJM |
Link |
|
Histamine |
Plasmodium falciparum |
Blood |
|
> |
|
|
|
|
|
|
|
43 |
On admission: SM (+ DIC) > HC, NM; day 3: SM > UM > HC, NM (levels ↑ 3 days after start of treatment and ↓ thereafter) |
Srichaikul et al., 1976, Trans R Soc Trop Med Hyg |
Link |
|
Histamine |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
50 |
Malaria (UM + CM) > HC |
Enwonwu et al., 2000, J Neural Transm |
Link |
|
Histidine |
N.I. |
Plasma |
|
|
|
|
|
= |
|
|
< |
126 |
N.I. |
Lopansri et al., 2006, Infect Immun |
Link |
|
Histidine |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
50 |
Malaria (UM + CM) > HC; ↑ apparent Km and ↑ (calculated) brain uptake by BBB transporter for malaria group compared with HC |
Enwonwu et al., 1999, QJM |
Link |
|
HMGB1 |
Plasmodium falciparum |
Plasma |
|
> |
|
|
|
|
> |
|
|
103 |
HMGB1 can discriminate between fatal and non-fatal P. falciparum malaria (ROC analysis); secretion by PBMCs exposed to P. falciparum malaria in vitro |
Higgins et al., 2013, Malar J |
Link |
|
HMGB1 |
Plasmodium falciparum |
Serum |
|
|
= |
|
|
= |
= |
|
> |
97 |
|
Angeletti et al., 2013, Am J Trop Med Hyg |
Link |
|
HMW-kininogen |
Plasmodium vivax |
Plasma |
|
|
|
|
|
|
|
|
|
12 |
P. vivax < HC |
Roy et al., 1988, Indian J Malariol |
Link |
|
HO-1 |
Plasmodium falciparum |
Brain (PM)-IHC |
|
|
|
|
> |
|
|
|
|
10 |
Selective expression in areas of bleedings, in Dürck’s granulomas, coexpression with CD68 (MF marker) |
Schluesener et al., 2001, Acta Neuropathol |
Link |
|
Human neutrophil lipocalin (HNL) |
Plasmodium falciparum, Plasmodium vivax |
Plasma |
|
|
|
|
|
|
> |
= |
|
65 |
+ correlation with MPO, lysozyme, parasitemia, body temperature and pulse rate |
Mohammed et al., 2003, Acta Trop |
Link |
|
iC3 |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
47 |
SM < HC; + correlation with C3; - correlation with SC5b-9 and TNF-a |
Wenisch et al., 1997, Clin Immunol Immunopathol |
Link |
|
iC3:C3 |
Plasmodium falciparum |
Plasma |
|
|
|
|
|
|
|
|
|
47 |
SM > HC; normalized 7 days after start of treatment |
Wenisch et al., 1997, Clin Immunol Immunopathol |
Link |
|
ICAM-1 (CD54) |
Plasmodium falciparum |
Brain (PM)-IHC |
|
|
= |
|
> |
|
|
|
|
21 |
+ correlation with sequestration of pRBC; only vascular staining; receptor staining also in vessels without pRBC sequestration → receptor ↑ is result of pRBC binding to a specific EC, and of systemically produced soluble mediators; also pRBC sequestration without receptor expression; receptor staining and pRBC sequestration in cerebellum > receptor staining and pRBC sequestration in cerebrum and brainstem |
Armah et al., 2005, Ann Trop Med Parasitol |
Link |
|
ICAM-1 (CD54) |
Plasmodium falciparum |
Brain (PM)-IHC |
|
|
|
|
> |
|
|
|
|
18 |
No staining in brains from patients who died from NM causes |
Ockenhouse et al., 1992, J Exp Med |
Link |
|
ICAM-1 (CD54) |
Plasmodium falciparum |
Brain (PM)-IHC |
|
|
|
|
> |
|
|
|
|
18 |
+ correlation with sequestration of pRBC; also increased expression in muscle, kidneys and lungs |
Turner et al., 1994, Am J Pathol |
Link |
|
ICAM-1 (CD54) |
Plasmodium falciparum |
Brain (PM)-IHC |
|
|
= |
|
> |
|
|
|
|
24 |
N.I. |
Brown et al., 1999, Neuropathol Appl Neurobiol |
Link |
|
ICAM-1 (CD54) |
Plasmodium falciparum |
Endothelial cells (subcutaneous fat tissue) |
|
|
|
|
|
|
|
|
|
37 |
CM > HC |
Moxon et al., 2013, Blood |
Link |
|
ICAM-1 (CD54) |
Plasmodium falciparum |
PBMC |
|
|
|
|
|
|
|
|
|
356 |
Malaria (SM + UM) > convalescent samples; a larger ↑ in the expression of ICAM-1 on monocytes is independently associated with SM |
Jenkins et al., 2006, Trans R Soc Trop Med Hyg |
Link |